In order to determine whether stroke drives an increase in peripheral sCD163 production in vivo, peripheral venous blood was collected within 24 hours of symptom onset, and expression of ADAM17 and CD163 was assessed at both the RNA and protein level using a combination of qRT-PCR, enzyme activity assay, and ELISA. This evidence concerns the gene ADAM17 and stroke disorder.